Posted in | News

Skanska Invests EUR 23 Million for Second Phase of Ruskeasuo Office Project

Skanska Commercial Development Nordic (STO:SKAB) is to initiate the second phase of its Ruskeasuo office project in Helsinki.

The investment amounts to EUR 23 M, approximately SEK 210 M and Skanska Finland’s construction contract amounts to EUR 16.4 M, or SEK 150 M, which is included in the order bookings for the fourth quarter.

The building will comprise approximately 7,500 square meters on eight floors around a central atrium. The project is the second phase of four office buildings that are planned along Mannerheim Street at the northern approach to Helsinki.

The target of the design is to create energy-efficient buildings that fulfill the requirements for certification in accordance with LEED Platinum, the international environmental rating system’s highest level.

Construction work, which will commence in April 2011, is scheduled for completion in August 2012. Preparatory ground work and construction of the project’s three basement floors for parking and other purposes was initiated as part of the first phase.

The Lintulahti office, which was the first project for Skanska Commercial Development Nordic in Helsinki, was completed in 2009. The LEED Platinum-certified building was sold earlier this year to the German company Commerz Real for EUR 38.4 M.

Skanska Commercial Development Nordic initiates and develops property projects in offices, logistics centers and retail warehouses. Office operations focus on the four large metropolitan regions in Sweden, the Copenhagen region in Denmark, Helsinki region in Finland and Oslo in Norway. The development of logistics centers and volume retail properties is conducted in strategic locations in Sweden, Denmark, Finland and Norway.

Source: http://www.skanska.com

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.